MRI: Development of ScaleMed: A Platform for Scalable mHealth Research and Development

MRI：ScaleMed 的开发：可扩展的移动医疗研究和开发平台

• 批准号: 1429047
• 负责人: Ashutosh Sabharwal
• 金额: $ 40万
• 依托单位: William Marsh Rice University
• 依托单位国家: 美国
• 项目类别: Standard Grant
• 财政年份: 2014
• 资助国家: 美国
• 起止时间: 2014-08-01 至 2018-07-31
• 项目状态: 已结题
• 来源: https://www.nsf.gov/awardsearch/showAward?AWD_ID=1429047&HistoricalAwards=false
• 关键词: MRI; Development; ScaleMed; Platform; Scalable

This project, designing and developing 'ScaleMed', an open-source instrument, aims to accelerate the progression of mHealth technologies from lab prototypes to at-scale clinical trials. The instrument impacts the area of healthcare, currently one of the biggest societal challenges. By providing a streamlined method to include diverse devices, the instrument will make significant contributions to the field. Using open-standards-compliant protocols, ScaleMed will help open doors to new at-scale clinical trials and lower the technology barrier. Since the infrastructure will be open-source and will serve as a community resource, its impact will scale with its user populations. Finally, the educational and outreach plan will certainly have a high impact, in the critical area of mHealth.The instrument consists of three components: Hardware Adaptor; Medical Application Modules, Libraries and Templates; and Cloud Control and Management. The instrument will be available as open-source to the entire community. Its immediate deployment is foreseen in three mHealth projects currently led by the PIs: SOLVD: a smartphone based tracking systems for conditions of depression; mobileVision, a smartphone based retinal imager; and mobileSpiro, a portable personalized spirometer.

该项目设计和开发“缩小”（一种开源工具），旨在加快MHealth技术从实验室原型到尺度临床试验的发展。该工具影响了医疗领域，这是目前最大的社会挑战之一。通过提供一种简化的方法来包括各种设备，该仪器将为该领域做出重大贡献。使用符合开放标准的协议，Scalemed将有助于打开新的尺度临床试验的大门，并降低技术障碍。由于基础架构将是开源的，并将作为社区资源，因此其影响将随用户群体扩展。最后，在MHealth的关键领域，教育和外展计划肯定会产生很大的影响。该工具由三个组成部分组成：硬件适配器；医疗应用模块，库和模板；以及云控制和管理。该仪器将作为开放源代码提供给整个社区。它的即时部署将在PIS：SOLVD：基于智能手机的抑郁症状的跟踪系统中预见到三个MHealth项目。 MobileVision，一种基于智能手机的视网膜成像仪；和Mobilespiro，一种便携式个性化的肺活量计。